Endocrine Abstracts

Contents

• Speaker Abstracts
• • CME TRAINING DAY
  • • Physiology and developmental disorders of the pituitary

      ea0030s1
    • Causes, diagnosis and management of pituitary dysfunction

      ea0030s2
    • The surgical management of pituitary tumours

      ea0030s3
    • Genetic disorders of thyroid physiology and development

      ea0030s4
    • Hypothyroidism

      ea0030s5
    • Hyperthyroidism and its management

      ea0030s6
  • MAIN MEETING
  • • Abstract unavailable

      ea0030s7
    • Gender reassignment surgery in GID

      ea0030s8
  • Symposium 2 Controversies in Paediatric Endocrinology
  • • GH in transition

      ea0030s9
    • MEN syndromes - genetics and ethics of screening

      ea0030s10
  • Symposium 3 The Olympiad!
  • • Beyond reasonable doubt: catching the GH cheats

      ea0030s11
    • Physical Activity and Athletic Training in Children and Adolescents

      ea0030s12
  • Symposium 4 Hot Topics in Diabetes
  • • Abstract unavailable

      ea0030s13
    • Continuous age appropriate structured education for children and young people with diabetes

      ea0030s14
  • Symposium 5
  • • Structured Knowledge and Information Programme-the SKIP course

      ea0030s15
    • How paediatric diabetes nurse specialists support schools

      ea0030s16
  • Symposium 6 Diabetes and Sport
  • • Physiology of exercise and endurance sport in type 1 diabetes

      ea0030s17
    • Optimising sports performance in type 1 diabetes

      ea0030s18
  • Keynote Lecture
  • • Insulin pumps and continuous glucose monitoring: the evidence

      ea0030s19
  • ENDOCRINE NURSES DAY
  • • Congenital hyperinsulinism the American experience

      ea0030s20
    • Abstract unavailable

      ea0030s21
  • Endocrine Nurse Session 1
  • • The Bare Bones

      ea0030s22
  • Case Presentation Endocrinology in Sport
  • • Abstract unavailable

      ea0030s23
  • Endocrine Nurse Session 2
  • • Egg and Ovarian tissue preservation. What can we offer to preserve fertility options for the future?

      ea0030s24
• Oral Communications
• • Oral Communications 1
  • • Iodine status in UK pregnant women and implications for fetal brain development

      ea0030oc1.1
    • Disease- and treatment-related factors implicated in late neuroendocrine morbidity after paediatric optic pathway gliomas: a preliminary multivariate analysis of 96 patients treated over 30 years

      ea0030oc1.2
    • Potential novel insights into the control of the feto-placental unit by kisspeptin

      ea0030oc1.3
    • Skeletal effects of hypothyroidism are mediated by thyroid hormone receptor [alpha]

      ea0030oc1.4
    • Ethnic differences in vascular growth factor levels in early life in relation to arterial stiffness in the Manchester heart and growth study

      ea0030oc1.5
    • A novel syndrome characterized by hypothalamic hormonal insufficiency, neonatal seizures, congenital abnormalities of the kidneys and urinary tract and obesity due to mutation in a gene regulating hypothalamic development

      ea0030oc1.6
    • Novel therapies herald novel diseases: The first paediatric case series of Graves' immune reconstitution disease

      ea0030oc1.7
    • Loss-of-function mutations in IGSF1 cause a novel, X-linked syndrome of central hypothyroidism and testicular enlargement

      ea0030oc1.8
  • Oral Communications 2
  • • Assessment of adrenal function in female to male adolescents with gender identity dysphoria

      ea0030oc2.1
    • Deficiency of the triple A syndrome gene product, ALADIN, renders human adrenal cells susceptible to oxidative stress with subsequent impact on steroidogenesis

      ea0030oc2.2
    • Does vitamin D modulate mitochondrial oxidative phosphorylation?

      ea0030oc2.3
    • Prenatal dexamethasone for treatment of congenital adrenal hyperplasia: a possible association with late gestational fetal demise in two cases

      ea0030oc2.4
    • Abnormal neurological and developmental outcomes in children with persistent and spontaneously resolving congenital hyperinsulinism

      ea0030oc2.5
    • Childhood body composition is associated with maternal plasma polyunsaturated fatty acids status in late pregnancy

      ea0030oc2.6
    • Growth, GH-IGF1 status and response to r-hGH therapy in 3-M syndrome, related to mutation status

      ea0030oc2.7
    • Genetic screening in a large cohort of patients with congenital hypopituitarism; current knowledge and future directions

      ea0030oc2.8
    • GH neuro-secretory dysfunction following traumatic brain injury in childhood

      ea0030oc2.9
    • When is it justifiable to await venous thyroid function tests before starting thyroxine treatment in infants referred with capillary TSH elevation?

      ea0030oc2.10
  • Oral Communications 3
  • • HbA1c league tables: does selection policy encourage foul play to support promotion to the 'premier league'?

      ea0030oc3.1
    • An audit of the management of diabetic ketoacidosis in children in a large teaching hospital

      ea0030oc3.2
    • Quality of life and HbA1c outcomes in children and young people commencing insulin pump therapy

      ea0030oc3.3
    • Continuous glucose monitoring: are there more barriers than benefits?

      ea0030oc3.4
    • Childhood type I diabetes education at time of diagnosis: what patients want to know

      ea0030oc3.5
  • Oral Communications 4
  • • Metformin in obese children and adolescents: the MOCA trial

      ea0030oc4.1
    • Patterns of presentation and initial management of type I diabetes mellitus in the UK: the early care survey

      ea0030oc4.2
    • White UK children are older, more obese and more insulin resistant than non-White UK children at diagnosis of type 2 diabetes: baseline results of the UK national type 2 diabetes cohort

      ea0030oc4.3
    • Vacuolar-type H+-ATPase V1A subunit is a molecular partner of Wolfram syndrome 1 protein, which regulates its stability and expression

      ea0030oc4.4
    • The effect of insulin intensification on glycaemic control and lipid levels in children and young persons with type 1 diabetes differs in relation to ethnic group

      ea0030oc4.5
  • Oral Communications 5
  • • Adolescent transition clinic: a review of the young person's self-confidence and future concerns

      ea0030oc5.1
    • Comparison of patient experiences of the glucagon and insulin pituitary provocation tests: time for a reappraisal

      ea0030oc5.2
    • A comparison of patient's preferences for attributes of GH delivery devices: children starting versus children established on GH treatment

      ea0030oc5.3
    • The role of the paediatric endocrine nurse in supporting the information needs of girls with Turner syndrome and their parents

      ea0030oc5.4
• Poster Presentations
• • (1)
  • • A homozygous glutathione peroxidase 1 mutation, p. Arg130-Leu133del, in a patient with familial glucocorticoid deficiency

      ea0030p1
    • Outcome of endoscopic transsphenoidal pituitary surgery in four paediatric Cushing's disease patients: a new therapeutic approach

      ea0030p2
    • The accuracy of diagnosing adrenal insufficiency in children undergoing glucagon stimulation test (GST)

      ea0030p3
    • The management of 21-hydroxylase deficiency: a retrospective audit in south east and west of Scotland

      ea0030p4
    • A rare case of virilizing adrenocorical carcinoma in a child presented with peripheral precocious puberty

      ea0030p5
    • The use of GH and anastrazole can help optimise linear growth in congenital adrenal hyperplasia due to CYP11B1 mutations

      ea0030p6
    • Growth and pubertal delay in autoimmune Addison's disease

      ea0030p7
    • The effect of homozygosity versus heterozygosity for IGFALS gene mutations on growth, bone strength and insulin resistance

      ea0030p8
    • Vitamin D trending: trends in vitamin D status, measurement and prescribing in Northern England, 2002-2011

      ea0030p9
    • A case of Noonan syndrome with a SHOC2 mutation associated with cortical and trabecular osteopenia and early onset fragility fractures

      ea0030p10
    • Dietary calcium restriction in idiopathic infantile hypercalcemia does not adversely affect spinal and distal radial bone mineral density: report on nine patients

      ea0030p11
    • An unusual case of hypercalciuria with hypophosphataemia and hyperphosphaturia

      ea0030p12
    • Managing hypercalcaemia in subcutaneous fat necrosis of the newborn

      ea0030p13
    • A neonate with hypocalcaemia caused by co-existing vitamin D deficiency and congenital hypoparathyroidism

      ea0030p14
    • Generalised arterial calcification of infancy

      ea0030p15
    • A case of Camurati-Engelmann disease with endocrine complications due to a missense mutation of the TGFB1 gene

      ea0030p16
    • Acute mesenteric ischaemia: a thrombotic complication of diabetic ketoacidosis?

      ea0030p17
    • The Euro-WABB Registry: differences in prevalence of diabetes between Wolfram, Alstrom, and Bardet-Biedl syndromes

      ea0030p18
    • Adolescent diabetes and emerging adulthood: effectiveness of a robust and staged joint-care transition pathway

      ea0030p19
    • Uptake of 2009 BSPED guidelines in Northern East England and North Cumbria

      ea0030p20
    • Pigmentary hypertrichosis and non-autoimmune insulin dependent diabetes mellitus syndrome is associated with severe chronic inflammation and cardiomyopathy, and represents a new monogenic autoinflammatory syndrome

      ea0030p21
    • Newly diagnosed type 1 diabetes: similarities and differences in initial management guidelines

      ea0030p22
    • Results from 23 years of continuous diabetes audit

      ea0030p23
    • Severe hypercalcaemia secondary to severe, prolonged metabolic acidosis in a patient with DKA

      ea0030p24
    • Review of guidelines for the management of children and adolescent with diabetes requiring surgery in three regions of England

      ea0030p25
    • Co-morbidities in children and young people with type 1 diabetes: who is responsible for management?

      ea0030p26
    • Cerebral oedema in toddlers; risks and challenges: a case series

      ea0030p27
    • Improvement in HbA1c following change from three times daily injections to a basal bolus insulin regimen in the Lothian paediatric diabetes population

      ea0030p28
    • Should we check vitamin D status at time of diagnosis of type 1 diabetes mellitus?

      ea0030p29
    • Audit of diabetic ketoacidosis management in adolescents in paediatric and adult care settings

      ea0030p30
    • Type 1 diabetes in a child with aplastic anaemia

      ea0030p31
    • Gonadotropin independent precocious puberty associated with later diagnosis of testicular embryonal carcinoma

      ea0030p32
    • Karyotype-phenotype correlations in height and pubertal outcomes of Turners patients

      ea0030p33
    • Abnormal glucose homeostasis in survivors of childhood acute lymphoblastic leukaemia treated with total body irradiation and bone marrow transplantation is associated with increased visceral and intramuscular fat

      ea0030p34
    • Late endocrine effects of non-craniopharyngioma, non-glioma brain tumours: descriptive analyses of patients referred to late-effects service

      ea0030p35
    • Audit of endocrine late effects in survivors of childhood brain tumours

      ea0030p36
    • Long-term morbidity after traumatic brain injury in childhood: fatigue, impact on cognition, health related quality of life and abnormal GH status

      ea0030p37
    • Cushing's syndrome due to POMC secretion from an abdominal yolk sac tumour in a 2 year old child

      ea0030p38
    • The impact of malaria in pregnancy on changes in blood pressure in children over the first year of life

      ea0030p39
    • Diagnostic yield in chondrodysplasias: a single centre study between 2002 and 2012

      ea0030p40
    • Two hour insulin/C peptide levels in oral glucose test: are they really necessary?

      ea0030p41
    • Feasibility of measuring birth length and parental height for small babies and following-up short children at 2 years

      ea0030p42
    • Prevalence and diagnosis of cholesteatoma in Turner syndrome

      ea0030p43
    • Risk factors for short term post-operative complications after pancreatectomy for congenital hyperinsulinism

      ea0030p44
    • Hyperinsulinaemic hypoglycaemia in newborn twins

      ea0030p45
    • Extraction of high quality RNA from fresh frozen and formalin fixed paraffin embedded human pancreatic tissues samples of patients with congenital hyperinsulinism for gene expression microarray

      ea0030p46
    • Beckwith-Wiedemann syndrome with paternally inherited duplication of chromosome 11p and a deletion of the long arm of chromosome 11

      ea0030p47
    • Comparing common methods of body composition assessments with magnetic resonant imaging in patients at high risk of sarcopenia and abnormal body proportions

      ea0030p48
    • Mind over muscle: investigating the biology of fatigue in GH deficiency using 31P-MRS

      ea0030p49
    • Adiponectin levels are inversely related to length in early infancy

      ea0030p50
    • Growth and glucose homeostasis after 2 years in children with inflammatory bowel disease receiving recombinant GH therapy for growth retardation

      ea0030p51
    • Puberty phases: an evaluation of a new system for rating puberty in paediatric practice

      ea0030p52
    • High rates of non adherence to daily r-hGH injections revealed by the easypod electronic dose record

      ea0030p53
    • Management of childhood-onset GH deficiency in young adulthood

      ea0030p54
    • Outcomes of paediatric craniopharyngioma: a single centre experience

      ea0030p55
    • Human GH (somatotropin) for growth failure in children

      ea0030p56
    • Grave problem, unrelated to fracture

      ea0030p57
    • Key efficacy issues in the use of recombinant human GH in children with prader-willi syndrome

      ea0030p58
    • Assessment of endocrinological, ophthalmological and radiological abnormalities in the irish paediatric cohort of septo-optic dysplasia

      ea0030p59
    • Septo-optic dysplasia and X-linked adrenoleukodystrophy: two rare conditions presenting together

      ea0030p60
    • A prospective study of pubertal growth in children with inflammatory bowel disease

      ea0030p61
    • Audit of children with thyrotoxicosis treated with antithyroid drugs by block and replacement regime: relapse rate and outcomes

      ea0030p62
    • A regional survey of postnatal management of babies at risk of neonatal thyrotoxicosis

      ea0030p63
    • Rhabdomyolysis and hypoglycaemia in profound hypothyroidism

      ea0030p64
    • Thyroid Hormone resistance: a case report

      ea0030p65
    • A case of GH deficiency?

      ea0030p66